CTOs on the Move


 
JEOL USA, Inc. is a wholly owned subsidiary of JEOL, Ltd. of Akishima, Japan.JEOL USA, Inc. was incorporated in the United States in 1962, and moved to present corporate offices at 11 Dearborn Road in Peabody, Massachusetts, in August 1979. The primary
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Samsung Medison Co.

Samsung Medison Co. is a Cypress, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

bill tobin

bill tobin is a Port Chester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ARC Devices

ARC Devices is a wireless, non-contact, vital signs and medical devices monitor innovator. Founded in 2012 we create world class vital signs monitors and medical devices for clinical professionals as well as responsible consumers; ensuring that you recieve the latest benefits of the personal health-care revolution. With an ever increasing awareness of health care becoming an essential element of modern life we take pride in our reputation for excellence and originality, maintaining the highest industry standards in both our products and our consumer service. By focusing on creativity, imagination, and invention we push the boundaries of technology to meet your needs in an increasingly fast paced, health concious, world. From family friendly, non-contact thermometers, to futuristic vital signs monitors, we create easy-to-use precision instruments which are small enough to fit in the palm of your hand. As the global medical revolution gains pace the team at Arc Designs continues to innovate and take the first leaps towards the next generation of personalized healthcare. We believe in a better future and so we look to the stars to improve the ground on which you stand.

Vitale Group

Vitale Group is a Lutherville Timonium, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Claret Medical

Claret Medical has been the leader in the field of cerebral protection since 2011, with approximately 97% market share in Europe, and is the first in the category to be commercially available in the U.S.